Excelsior Sciences

Excelsior Sciences is a chemistry and technology company focused on accelerating small-molecule discovery and manufacturing. Its platform uses “blocc chemistry”: a modular approach to carbon–carbon bond formation built around smart, machine-ready chemical building blocks. Designed for automation, artificial intelligence, and use by non-specialists, the method aims to make chemical synthesis faster and more iterative than traditional manual techniques.

The company combines automated synthesis and testing with AI-guided models in closed-loop learning and discovery. These processes are intended to improve predictions of pharmaceutical properties—including solubility, permeability, toxicity, and metabolism—and help identify molecules with targeted functions. Excelsior’s platform is designed to connect digital discovery with physical chemistry, support broader exploration of molecular ideas, and scale production from initial milligram quantities to kilograms. The company also highlights local automated manufacturing as a way to strengthen supply chains. Excelsior is starting with medicines while pursuing broader applications for its chemistry platform. Its scientific work includes publications on closed-loop discovery, automated carbon–carbon bond formation, and organic laser emitters.